TA-MSCs release tumor-promoting inflammatory cytokines and chemokines, including IL-6, IL-8, VEGF, and SDF-1, enhancing their oncogenic characteristics [30, 42, 96, 101]. This evidence concerns the gene CXCL12 and neoplasm.